Eli Lilly To Purchase Cooley-Led CrossBridge In $300M Deal
By Jade Martinez-Pogue · April 14, 2026, 4:44 PM EDT
CrossBridge Bio Inc., a venture-backed pre-clinical biotechnology firm advised by Cooley LLP, announced Tuesday that it has agreed to be bought by pharmaceutical giant Eli Lilly & Co. in a deal...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login